We and others have previous shown that CRAd-mediated TRAIL gene therapy for leukemia and breast cancer resulted in significant increases of cell killing and suppression of tumor growth by inducing apoptosis [8,52]. This evidence concerns the gene TNFSF10 and neoplasm.